Biomedical Engineering Reference
In-Depth Information
[27] G. Weibrich, T. Hansen, W. Kleis, R. Buch, W.E. Hitzler, Effect of platelet concentration in platelet-rich
plasma on peri-implant bone regeneration, Bone 34 (2004) 665-671.
[28] W. Richter, Mesenchymal stem cells and cartilage in situ regeneration, J. Intern. Med. 266 (2009) 390-405.
[29] T.E. Ichim, D.T. Alexandrescu, F. Solano, F. Lara, N. Campion Rde, E. Paris, et al., Mesenchymal stem
cells as anti-inflammatories: implications for treatment of Duchenne muscular dystrophy, Cell. Immunol.
260 (2010) 75-82.
[30] A.J. Friedenstein, K.V. Petrakova, A.I. Kurolesova, G.P. Frolova, Heterotopic of bone marrow. Analysis of
precursor cells for osteogenic and hematopoietic tissues, Transplantation 6 (1968) 230-247.
[31] A.C.W. Zannettino, S. Paton, A. Arthur, F. Khor, S. Itescu, J.M. Gimble, et al., Multipotential human
adipose-derived stromal stem cells exhibit a perivascular phenotype in vitro and in vivo, J. Cell Physiol. 214
(2008) 413-421.
[32] M.Q. Wickham, G.R. Erickson, J.M. Gimble, T.P. Vail, F. Guilak, Multipotent stromal cells derived from the
infrapatellar fat pad of the knee, Clin. Orthop. Relat. Res. (2003) 196-212 doi:10.1097/01.blo.0000072467
.53786.ca.
[33] M.J. Hoogduijn, M.J. Crop, A.M. Peeters, G.J. Van Osch, A.H. Balk, J.N. Ijzermans, et al., Human heart,
spleen, and perirenal fat-derived mesenchymal stem cells have immunomodulatory capacities, Stem Cells
Dev. 16 (2007) 597-604.
[34] Y.-Y. Jo, H.J. Lee, S.Y. Kook, H.W. Choung, J.Y. Park, J.H. Chung, et al., Isolation and characterization of
postnatal stem cells from human dental tissues, Tissue Eng. 13 (2007) 767-773.
[35] Q. He, C. Wan, G. Li, Concise review: multipotent mesenchymal stromal cells in blood, Stem Cells 25
(2007) 69-77.
[36] W. Oh, D.-S. Kim, Y.S. Yang, J.K. Lee, Immunological properties of umbilical cord blood-derived mesen-
chymal stromal cells, Cell. Immunol. 251 (2008) 116-123.
[37] D.L. Morganstein, P. Wu, M.R. Mane, N.M. Fisk, R. White, M.G. Parker, Human fetal mesenchymal stem
cells differentiate into brown and white adipocytes: a role for ERRalpha in human UCP1 expression, Cell
Res. 20 (2010) 434-444.
[38] L. Marinucci, S. Balloni, E. Becchetti, G. Bistoni, E.M. Calvi, E. Lumare, et al., Effects of hydroxyapatite
and biostite((R)) on osteogenic induction of hMSC, Ann. Biomed. Eng. 38 (2010) 640-648.
[39] G. Lepski, C.E. Jannes, J. Maciaczyk, A. Papazoglou, A.T. Mehlhorn, S. Kaiser, et al., Limited Ca
2
and
PKA-pathway dependent neurogenic differentiation of human adult mesenchymal stem cells as compared
to fetal neuronal stem cells, Exp. Cell Res. 316 (2010) 216-231.
[40] A.J. Engler, S. Sen, H.L. Sweeney, D.E. Discher, Matrix elasticity directs stem cell lineage specification,
Cell 126 (2006) 677-689.
[41] Y. Liu, X. Han, Z. Sun, B. Chen, Q. Han, J. Li, et al., Flk-1
adipose-derived mesenchymal stem cells dif-
ferentiate into skeletal muscle satellite cells and ameliorate muscular dystrophy in mdx mice, Stem Cells
Dev. 16 (2007) 695-706.
[42] M. Chivu, S.O. Dima, C.I. Stancu, C. Dobrea, V. Uscatescu, L.G. Necula, et al., In vitro hepatic differentia-
tion of human bone marrow mesenchymal stem cells under differential exposure to liver-specific factors,
Transl. Res. 154 (2009) 122-132.
[43] H. Agis, B. Kandler, M.B. Fischer, G. Watzek, R. Gruber, Activated platelets increase fibrinolysis of mesen-
chymal progenitor cells, J. Orthop. Res. 27 (2009) 972-980.
[44] J.P. Vogel, K. Szalay, F. Geiger, M. Kramer, W. Richter, P. Kasten, Platelet-rich plasma improves expansion
of human mesenchymal stem cells and retains differentiation capacity and in vivo bone formation in cal-
cium phosphate ceramics, Platelets 17 (2006) 462-469.
[45] Y. Mishima, M. Lotz, Chemotaxis of human articular chondrocytes and mesenchymal stem cells, J. Orthop.
Res. 26 (2008) 1407-1412.
[46] Y. Ozaki, M. Nishimura, K. Sekiya, F. Suehiro, M. Kanawa, H. Nikawa, et al., Comprehensive analysis of
chemotactic factors for bone marrow mesenchymal stem cells, Stem Cells Dev. 16 (2007) 119-129.
